Kindstar Globalgene Technology, Inc. (9960.HK)
9960.HK Stock Price Chart
Explore Kindstar Globalgene Technology, Inc. interactive price chart. Choose custom timeframes to analyze 9960.HK price movements and trends.
9960.HK Company Profile
Discover essential business fundamentals and corporate details for Kindstar Globalgene Technology, Inc. (9960.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
16 Jul 2021
Employees
3.01K
Website
https://www.kindstar.com.cnCEO
Shiang Huang
Description
Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.
9960.HK Financial Timeline
Browse a chronological timeline of Kindstar Globalgene Technology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Mar 2026
Upcoming earnings on 26 Mar 2026
Earnings released on 26 Aug 2025
Dividend declared on 9 Jun 2025
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 27 Aug 2025.
Earnings released on 5 Jun 2025
Earnings released on 28 Mar 2025
EPS came in at -$0.04 falling short of the estimated $0.06 by -158.82%, while revenue for the quarter reached $241.61M , missing expectations by -65.39%.
Earnings released on 25 Mar 2025
EPS came in at -$0.04 , while revenue for the quarter reached $251.32M .
Earnings released on 28 Aug 2024
EPS came in at $0.01 falling short of the estimated $0.06 by -89.64%, while revenue for the quarter reached $254.16M , missing expectations by -78.33%.
Dividend declared on 7 Jun 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 29 Aug 2024.
Earnings released on 5 Jun 2024
EPS came in at $0.01 , while revenue for the quarter reached $256.05M .
Earnings released on 27 Mar 2024
EPS came in at -$0.00 falling short of the estimated $0.04 by -103.52%, while revenue for the quarter reached $262.59M , missing expectations by -77.61%.
Earnings released on 14 Nov 2023
EPS came in at -$0.00 , while revenue for the quarter reached $254.46M .
Earnings released on 18 Aug 2023
EPS came in at $0.03 falling short of the estimated $0.03 by -20.05%, while revenue for the quarter reached $281.24M , missing expectations by -50.74%.
Earnings released on 30 Jun 2023
EPS came in at $0.02 , while revenue for the quarter reached $266.44M .
Earnings released on 28 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.05 by -75.91%, while revenue for the quarter reached $399.37M , missing expectations by -66.60%.
Earnings released on 31 Dec 2022
EPS came in at $0.01 , while revenue for the quarter reached $414.06M .
Earnings released on 16 Aug 2022
EPS came in at $0.04 falling short of the estimated $0.05 by -18.72%, while revenue for the quarter reached $406.38M , missing expectations by -34.12%.
Earnings released on 30 Jun 2022
EPS came in at $0.04 , while revenue for the quarter reached $386.02M .
Earnings released on 25 Mar 2022
EPS came in at $0.03 , while revenue for the quarter reached $297.00M .
Earnings released on 31 Dec 2021
EPS came in at $0.03 , while revenue for the quarter reached $301.48M .
Earnings released on 31 Aug 2021
EPS came in at -$6.12 , while revenue for the quarter reached $259.45M .
Earnings released on 30 Jun 2021
EPS came in at -$6.20 , while revenue for the quarter reached $263.06M .
Earnings released on 25 Feb 2021
EPS came in at -$4.29 , while revenue for the quarter reached $263.32M .
Earnings released on 31 Dec 2020
EPS came in at -$4.46 , while revenue for the quarter reached $274.27M .
9960.HK Stock Performance
Access detailed 9960.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.